Recruiting Numbers
emovis is not only known for its high recruiting numbers. It is also recognized for maintaining and/or exceeding the forecasted study participants recruiting prospects. The reason: emovis demonstrates high-level expertise and is open to innovation when recruiting patients and the Executive Management typically estimates the number of recruits in a conservative manner. A rule of fairness at emovis: Up to now, numerous sponsors were surprised and quite happy.
Search our past trials and recruitment numbers
| Start | Indication | Sponsor | Time period | Recruited | Trial Identifier |
|---|---|---|---|---|---|
| 2006 | Restless Legs Syndrome | Boehringer Ingelheim International GmbH | 7 Monate | 21 | EudraCT-2005-005225-54 |
| 2009 | Contraception | Bayer AG | 60 | EudraCT-2009-010599-45 | |
| 2006 | Restless Legs Syndrome | GlaxoSmithKline PLC | 4 Monate | 3 | |
| 2009 | Depression | Bayer AG | 102 | EudraCT-2006-000525-60 | |
| 2006 | Irritable Bowel Syndrome | GlaxoSmithKline PLC | 3 months | 28 | |
| 2007 | Schizophrenia | Johnson & Johnson GmbH | |||
| 2006 | Depression | AstraZeneca PLC | 4 Monate | 13 | EudraCT- 2005-003745-14 |
| 2007 | Stress Urinary Incontinence | Lilly Deutschland GmbH | 2 | ||
| 2006 | Anxiety Disorder (GAD) | AstraZeneca PLC | 9 Monate | 7 | EudraCT- 2005-005055-18 |
| 2007 | Addiction (Alcohol) | Norgine B.V. | 11 | ||
| 2006 | Restless Legs Syndrome | Axxonis Pharma AG | 10 Monate | 26 | EudraCT-2004-001589-42 |
| 2007 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 24 | 24 EudraCT-2010-024191-25 | |
| 2006 | Insomnia | Sanofi-Aventis Deutschland GmbH | 18 Monate | 31 | EudraCT- 2005-003082-16 |
| 2006 | Restless Legs Syndrome | Schwarz Pharma AG | 21 | EudraCT-2005-000428-18 | |
| 2006 | Restless Legs Syndrome | Imerem GmbH, Schwarz Pharma AG | 2 Monate | 11 | EudraCT-2004-001589-42 |
| 2006 | Restless Legs Syndrome | Schwarz Pharma AG | 11 | EudraCT-2005-002611-25 | |
| 2006 | Depression | Sanofi-Aventis Deutschland GmbH | 4 Monate | 42 | EudraCT - 2004-002327-41 |
| 2004 | Alzheimer's disease | Sanofi-Aventis Deutschland GmbH | 4 | GDCT0030961 | |
| 2006 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 3 Monate | 46 | EudraCT-2004-004009-10 |
| 2004 | Restless Legs Syndrome | Schwarz Pharma AG | 20 | ||
| 2006 | Depression | GlaxoSmithKline PLC | 3 Monate | 21 | EudraCT-2006-001877-13 |
| 2004 | Diabetes mellitus | Schwarz Pharma AG | 19 | ||
| 2006 | Restless Legs Syndrome | Imerem GmbH | 2 Monate | 12 | |
| 2004 | Diabetes mellitus | Schwarz Pharma AG | 7 | EudraCT-2004-000551-42 | |
| 2005 | Anxiety Disorder (Panic) | Albion Pharmaceuticals Ltd. | 1 Monat | 12 | EudraCT-2005-005708-17 |
| 2003 | Depression | Dr. Willmar Schwabe GmbH & Co. KG | 4 | ||
| 2005 | Bronchitis | Bionorica SE | 2 Wochen | 3 | EudraCT-2005-003249-15 |
| 2020 | Vaccination | Vakzine Projekt Management GmbH | 350 | ||
| 2005 | Premenstrual Syndrome | Wyeth LLC. | 8 Monate | 3 | EudraCT-2004-005173-27 |
| 2019 | Vaccination | Sanofi Pasteur SA | 1 month | 99 | EudraCT-2019-000655-14 |
| 2005 | Depression | Boehringer Ingelheim International GmbH | 7 Monate | 9 | |
| 2005 | Anxiety Disorder (GAD) | Lilly Deutschland GmbH | 8 Monate | 17 | EudraCT-2004-002626-22 |
| 2005 | Irritable Bowel Syndrome | Yamanouchi Pharma GmbH | 2 months | 12 | |
| 2005 | Depression | GlaxoSmithKline PLC | 2 Monate | 1 | EudraCT-2004-003803-19 |
| 2004 | Anxiety Disorder (GAD) | Lilly Deutschland GmbH | 10 Monate | 14 | |
| 2004 | Anxiety Disorder (Phobia) | GlaxoSmithKline PLC | 5 Monate | 35 | EudraCT-2004-000848-24 |
| 2004 | Irritable Bowel Syndrome | GlaxoSmithKline PLC | 5 months | 49 | |
| 2017 | Alzheimer-Disease | Biogen Inc. | 18 months | 55 | |
| 2004 | Depression | GlaxoSmithKline PLC | 8 Monate | 31 | |
| 2016 | Irritable Bowel Syndrome | Laves-Arzneimittel GmbH | 4 Monate | 11 | EudraCT-2011-001743-78 |
| 2004 | Depression | Wyeth LLC. | 3 Monate | 27 | EudraCT-2004-000562-13 |
| 2016 | Onychomycosis | Polichem S.A. | 5 Monate | 60 | EudraCT-2015-000561-31 |
| 2004 | Depression | Imerem GmbH, Schwarz Pharma AG | 6 months | 5 | |
| 2016 | Irritable Bowel Syndrome | SymbioPharm GmbH | 5 Monate | 33 | EudraCT- 2011-004593-29 |
| 2004 | Alzheimer-Disease | GlaxoSmithKline PLC | 8 Monate | 2 | EudraCT-2004-000985-12 |
| 2016 | COPD | AstraZeneca PLC | 3 Monate | 31 | EudraCT-2015-005444-33 |
| 2004 | Depression | Lilly Deutschland GmbH | 3 months | 50 | |
| 2016 | Contraception | Daiichi Sankyo Deutschland GmbH, Estetra SPRL | 5 Monate | 21 | EudraCT-2013-005164-26 |
| 2004 | Restless Legs Syndrome | Boehringer Ingelheim International GmbH | 3 months | 49 | |
| 2016 | Alzheimer-Disease | Pearl Therapeutics Ltd., Boehringer Ingelheim International GmbH | 6 months | 16 | EudraCT-2013-005040-28 |
| 2004 | Polyneuropathy, diabetic | INC Research Holdings Inc. | 4 months | 19 | |
| 2016 | Alzheimer-Disease | RB UK Commercial Ltd., Boehringer Ingelheim International GmbH | 1 month | 1 | EudraCT-2013-005031-24 |
| 2004 | Restless Legs Syndrome | Imerem GmbH | 6 Monate | 20 | EudraCT-2005-000428-18 |
| 2016 | Pain | ESPERION Therapeutics Inc., Boehringer Ingelheim International GmbH | 5 Monate | 90 | EUdraCT-2015-000404-25 |
| 2003 | Depression | Dr. Willmar Schwabe GmbH & Co. KG | 14 months | 58 | |
| 2015 | Diabetes mellitus | AstraZeneca PLC | 4 Monate | 9 | EudraCT-2015-002376-24 |
| 2003 | Alzheimer-Disease | Sanofi-Aventis Deutschland GmbH | 15 months | 15 | |
| 2016 | Lipometabolic disorder | ESPERION Therapeutics Inc. | 6 months | 12 | EudraCT-2016-004115-12 |
| 2003 | Depression | H. Lundbeck A/S | 7 months | 21 | |
| 2016 | Gastrointestinal Reflux Disease (GERD) | RB UK Commercial Ltd. | 5 Monate | 33 | EudraCT-2014-005261-69 |
| 2003 | Restless Legs Syndrome | UCB S.A. | 6 weeks | 32 | |
| 2016 | Asthma | AstraZeneca PLC | 1 Monat | 10 | EudraCT- 2004-004042-41 |
| 2003 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 2 months | 24 | |
| 2016 | Arthrosis | PBB Entrepreneur Ltd. | 4 Monate | 56 | |
| 2003 | Alzheimer-Disease | Janssen-Cilag GmbH | 4 months | 5 | |
| 2016 | Allergy (Grass pollen) | ALLERGOPHARMA GmbH & Co. KG | 2 Monate | 33 | EudraCT- 2015-002409-13 |
| 2003 | Addiction (Nicotine) | GlaxoSmithKline PLC | 4 days | 101 | |
| 2016 | Depression | Janssen-Cilag GmbH | 10 months | 3 | |
| 2002 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 3 months | 22 | |
| 2016 | Acute Infection | Vertex Inc. | 3 Monate | 1 | EudraCT- 2014-004068-39 |
| 2002 | Migraine | Bayer AG | 3 months | 10 | |
| 2015 | COPD | Pearl Therapeutics Ltd. | 4 Monate | 29 | EudraCT-2014-004712-10 |
| 2002 | Migraine | GlaxoSmithKline PLC | 4 months | 55 | |
| 2015 | Fibromyalgia | Daiichi Sankyo Deutschland GmbH | 7 Monate | 28 | EudraCT-2013-005164-26 |
| 2002 | Restless Legs Syndrome | Boehringer Ingelheim International GmbH | 3 months | 35 | |
| 2015 | Addiction (Nicotine) | Philip Morris Products S.A. | 1 Monat | 28 | EudraCT- 2013-002447-29 |
| 2002 | Restless Legs Syndrome | GlaxoSmithKline PLC | 3 months | 16 | |
| 2015 | COPD | AstraZeneca PLC | 4 Monate | 11 | EudraCT-2014-004715-37 |
| 2002 | Restless Legs Syndrome | GlaxoSmithKline PLC | 2 weeks | 9 | |
| 2015 | Depression | Alkermes PLC | 6 Monate | 48 | EudraCT-2014-000379-14 |
| 2002 | Schizophrenia | Janssen-Cilag GmbH | 6 months | 8 | |
| 2014 | COPD | GlaxoSmithKline PLC | 2 Monate | 15 | EudraCT-2014-000611-14 |
| 2002 | Depression | Dr. Willmar Schwabe GmbH & Co. KG | 10 months | 13 | |
| 2014 | COPD | GlaxoSmithKline PLC | 6 Wochen | 12 | EudraCT-2011-005914-12 |
| 2002 | Anxiety Disorder (GAD) | Orion Pharma GmbH | 5 months | 35 | |
| 2014 | COPD | Novartis AG | 2 Monate | 21 | EudraCT-2013-001477-25 |
| 2002 | Anxiety Disorder (Phobia) | GlaxoSmithKline PLC | 3 months | 25 | |
| 2014 | Vaccination | Sanofi Pasteur SA | 11 months | 6 | |
| 2001 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 3 months | 9 | |
| 2014 | Binge Eating Disorder | Shire Pharmaceuticals Group Plc | 1 Monat | 1 | EudraCT-2012-004457-88 |
| 2001 | Anxiety Disorder (Panic) | Wyeth LLC. | 12 months | 49 | |
| 2014 | Irritable Bowel Syndrome | Menarini Research & Business Service GmbH | 6 months | 15 | |
| 2001 | Anxiety Disorder (Panic) | Pfizer Inc. | 3 months | 4 | |
| 2013 | COPD | Almirall, S.A., AstraZeneca PLC | 3 Monate | 20 | EudraCT-2013-000116-14 |
| 2000 | Anxiety Disorder (Phobia) | Solvay SA | 3 months | 23 | |
| 2013 | Vaccination | GlaxoSmithKline PLC | 1 month | 16 | |
| 2000 | Depression | Boehringer Ingelheim International GmbH | 12 months | 60 | |
| 2013 | Obstipation | Ferring B.V. | 6 months | 24 | |
| 2017 | Migraine | CoLucid Pharmaceuticals, Inc. | 4 Monate | 17 | EudraCT-2015-005689-40 |
| 2013 | COPD | GlaxoSmithKline PLC | 1 week | 2 | |
| 2017 | Insomnia | Eisai Inc. | 10 months | 93 | EudraCT-2015-004347-39 |
| 2013 | Binge Eating Disorder | Shire Pharmaceuticals Group Plc | 2 Monate | 2 | Eudra CT-2012-003310-14 |
| 2017 | Irritable Bowel Syndrome | Dr. Willmar Schwabe GmbH & Co. KG | 9 months | 23 | EudraCT-2014-004702-14 |
| 2012 | Depression | H. Lundbeck A/S | 8 Monate | 19 | EudraCT-2012-001380-76 |
| 2017 | Depression | Janssen-Cilag GmbH | 11 months | 12 | EudraCT-2016-001929-14 |
| 2012 | Depression | Merck Sharp & Dohme GmbH | 10 months | 5 | |
| 2017 | Arthrosis | Astellas Pharma Inc. | 1 month | 22 | EudraCT-2014-004996-22 |
| 2012 | Depression | Shire Pharmaceuticals Group Plc | 12 Monate | 44 | EudraCT-2011-003018-17 |
| 2012 | Addiction (Nicotine) | Pfizer Inc. | 2 Jahre | 371 | EudraCT- 2010-022914-15 |
| 2017 | Vaccination | Pfizer Inc. | 16 months | 26 | EudraCT-2016-003866-14 |
| 2012 | COPD | Almirall, S.A. | 5 months | 27 | |
| 2016 | Urinary trakt infections | Repha GmbH Biologische Arzneimittel | 20 Monate | 22 | EudraCT-2013-004653-25 |
| 2012 | Irritable Bowel Syndrome | Laves-Arzneimittel GmbH | 2 years | 65 | |
| 2017 | Allergic Rhinitis | ALK-Abelló Arzneimittel GmbH | 1 Monat | 8 | EudraCT-2017-000971-97 |
| 2011 | Alzheimer-Disease | Avraham Pharmaceuticals Ltd. | 17 Monate | 32 | EudraCT-2010-021926-37 |
| 2017 | COPD | AstraZeneca PLC, Pearl Therapeutics Ltd. | 1 Monat | 18 | EudraCT-2016-000154-34 |
| 2011 | ADHS | Shire Pharmaceuticals Group Plc | 7 months | 10 | |
| 2017 | COPD | Verona Pharma PLC | 3 Monate | 16 | EudraCT-2016-005205-40 |
| 2011 | Alzheimer-Disease | Genetech Inc. | 4 Monate | 6 | EudraCT-2010-021926-37 |
| 2017 | Acute Infection | Medicago Inc. | 2 months | 92 | |
| 2011 | Restless Legs Syndrome | UCB S.A. | 4 Monate | 47 | EudraCT- 2011-000053-23 |
| 2018 | Alzheimer-Disease | Eisai Inc. | 9 months | 13 | EudraCT-2016-003928-23 |
| 2011 | Venous insufficiency | OM Pharma Ltd. | 4 Monate | 9 | EudraCT-2009-013391-44 |
| 2018 | Insomnia | Idorsia Pharmaceuticals Ltd. | 12 months | 239 | EudraCT-2017-004642-20 |
| 2011 | Psychiatric diagnosis, others | Weleda AG | 9 Monate | 201 | EudraCT- 2010-024189-23 |
| 2018 | Acute Infection | Medicago Inc. | 2 Wochen | 52 | EudraCT-2018-001894-26 |
| 2011 | Diabetes mellitus | MetaCure Germany GmbH | 10 months | 3 | |
| 2018 | Arthrosis | Regeneron Pharmaceuticals Inc. | 2 weeks | 23 | EudraCT-2017-001702-15 |
| 2011 | Depression | Takeda Pharmaceutical Company Ltd. | 5 Monate | 46 | EudraCT- 2011-005298-22 |
| 2018 | Onychomycosis | Moberg Pharma AB | 5 Monate | 127 | EudraCT-2016-001204-39 |
| 2011 | COPD | GlaxoSmithKline PLC | 9 months | 21 | |
| 2018 | Insomnia | Janssen-Cilag GmbH | 4 months | 32 | EudraCT-2017-000980-33 |
| 2011 | Hypertension | Servier Forschung und Pharma Entwicklung GmbH | 6 Monate | 25 | EudraCT- 2010-020945-28 |
| 2018 | Premenstrual Syndrome | Asarina Pharma AB | 6 Monate | 20 | EudraCT-2017-000822-37 |
| 2011 | ADHS | Novartis AG | 4 Monate | 70 | EudraCT-2011-004668-31 |
| 2018 | Uterusmyom | Bayer AG | 8 Months | 8 | EudraCT-2016-002855-48 |
| 2011 | Depression | AstraZeneca PLC | 5 Monate | 18 | EudraCT-2010-019925-33 |
| 2016 | Onychomycosis | Almirall, S.A. | 4 Monate | 59 | EudraCT-2015-000561-31 |
| 2011 | Psychiatric diagnosis, others | Dr. Willmar Schwabe GmbH & Co. KG | 4 months | 50 | |
| 2015 | Arthrosis | Regeneron Pharmaceuticals Inc. | 6 months | 48 | |
| 2011 | Diabetes mellitus | Boehringer Ingelheim International GmbH | 15 months | 18 | |
| 2015 | COPD | Novartis AG | 4 Monate | 15 | EudraCT-2013-003127-11 |
| 2014 | Diabetes mellitus | Hanmi Pharm.Co.,Ltd. | 5 months | 1 | EudraCT-2013-004250-13 |
| 2010 | Prophylaxis (Flu) | analyze & realize GmbH | 1 Monat | 60 | |
| 2013 | Depression | Allergan PLC | 12 Monate | 25 | EudraCT- 2012-001950-25 |
| 2010 | Vaccination | GlaxoSmithKline PLC | 2 Monate | 40 | |
| 2012 | COPD | Allergan PLC, Almirall, S.A., AstraZeneca PLC | 6 Monate | 27 | EudraCT-2011-001524-38 |
| 2011 | COPD | GlaxoSmithKline PLC | 6 Monate | 20 | EudraCT-2010-021802-39 |
| 2010 | Vaccination | Sanofi Pasteur SA | 2 months | 108 | |
| 2011 | Depression | AstraZeneca PLC | 5 Months | 18 | EudraCT-2010-019925-33 |
| 2008 | Anxiety Disorder (GAD) | H. Lundbeck A/S | 3 Monate | 10 | EudraCT-2008-001766-90 |
| 2010 | Depression | analyze & realize GmbH | 5 Monate | 95 | |
| 2008 | Depression | Takeda Pharmaceutical Company Ltd. | 8 Monate | 28 | EudraCT-2008-001580-11 |
| 2008 | Diabetes mellitus | Lilly Deutschland GmbH | 4 months | 4 | |
| 2010 | Obstipation | Shire Pharmaceuticals Group Plc | 32 months | 16 | |
| 2018 | Migraine | Merck Sharp & Dohme GmbH | 2 Months | 55 | |
| 2010 | Alzheimer-Disease | JSW Life Sciences GmbH | 6 Monate | 4 | |
| 2006 | Metrorrhagie | Bayer AG | 6 Monate | 11 | EudraCT- 2005-004340-32 |
| 2010 | Depression | Sanofi-Aventis Deutschland GmbH | 7 Monate | 33 | EudraCT-2009-010339-42 |
| 2006 | Parkinson Disease | Axxonis Pharma AG | 2 Monate | 1 | EudraCT-2006-003732-30 |
| 2006 | Restless Legs Syndrome | Boehringer Ingelheim International GmbH | 3 Monate | 21 | EudraCT-2005-006128-13 |
| 2010 | Alzheimer-Disease | Lilly Deutschland GmbH | 9 Monate | 4 | EudraCT-2008-002758-39 |
| 2003 | Diabetes mellitus | GlaxoSmithKline PLC | 8 months | 5 | |
| 2010 | Depression | GlaxoSmithKline PLC | 4 Monate | 22 | EudraCT- 2009-010339-42 |
| 2009 | Alzheimer-Disease | H. Lundbeck A/S | 9 Monate | 4 | |
| 2017 | Psoriasis | Novartis AG | 4 Monate | 4 | EudraCT-2015-005170-38 |
| 2009 | Addiction (Alcohol) | H. Lundbeck A/S | 10 Monate | 121 | EudraCT-2007-002315-92 |
| 2017 | Lipometabolic disorder | ESPERION Therapeutics Inc. | 9 months | 4 | |
| 2009 | Contraception | Bayer AG | 8 months | 148 | |
| 2012 | Alzheimer-Disease | Avraham Pharmaceuticals Ltd. | 17 Monate | 32 | EudraCT-2010-021926-37 |
| 2015 | Depression | Alkermes PLC | 5 Monate | 14 | EudraCT-2014-000380-41 |
| 2009 | Alzheimer-Disease | H. Lundbeck A/S | 7 Monate | 10 | |
| 2018 | Depression | Shire Pharmaceuticals Group Plc | 3 Months | 29 | EudraCT-2015-005282-22 |
| 2009 | Depression | H. Lundbeck A/S | 2 Monate | 6 | EudraCT-2007-001871-13 |
| 2018 | Insomnia | Idorsia Pharmaceuticals Ltd. | 1 month | 1 | EudraCT-2017-004644-38 |
| 2009 | Alzheimer-Disease | Servier Forschung und Pharma Entwicklung GmbH | 7 Monate | 7 | |
| 2018 | Depression | Janssen-Cilag GmbH | 3 months | 32 | EudraCT- 2017-002633-28 |
| 2009 | Diabetes mellitus | Novartis AG | 7 months | 6 | |
| 2019 | Depression | Janssen-Cilag GmbH | 3 months | 14 | EudraCT-2015-005282-23 |
| 2009 | Restless Legs Syndrome | Pfizer Inc. | 6 Monate | 16 | EudraCT-2008-005889-32 |
| 2019 | Irritable Bowel Syndrome | Cosmo Pharmaceuticals NV | 4 months | 62 | EudraCT-2016-004977-42 |
| 2009 | Diabetes mellitus | Boehringer Ingelheim International GmbH | 8 months | 2 | |
| 2019 | Cardiovascular Diesase | Novartis AG | 4 Monate | 35 | EudraCT-2018-003786-34 |
| 2009 | Arthrosis | Lilly Deutschland GmbH | 4 months | 12 | |
| 2009 | Addiction (Alcohol) | Pierrel S.p.A. | 15 Monate | 28 | EudraCT-2007-002315-92 |
| 2019 | Obesity | Novo Nordisk A/S | 3 Months | 11 | Eudra CT-2017-003380-35 |
| 2009 | Depression | Takeda Pharmaceutical Company Ltd. | 1 Monat | 49 | EudraCT-2008-001581-91 |
| 2019 | Insomnia | Idorsia Pharmaceuticals Ltd. | 4 Months | 7 | EudraCT-2017-004644-38 |
| 2009 | Insomnia | GlaxoSmithKline PLC | 2 Monate | 29 | EudraCT-2008-006345-72 |
| 2019 | Acute Infection | Sanofi Pasteur SA | 1 month | 99 | EudraCT-2019-000655-14 |
| 2009 | Diabetes mellitus | Lilly Deutschland GmbH | 2 months | 4 | |
| 2019 | Alopecia Areata | Pfizer Inc. | 3 Months | 3 | EudraCT-2018-001714-14 |
| 2008 | Vaccination | Merck Sharp & Dohme GmbH | 8 months | 844 | |
| 2019 | Atopic Dermatitis | Pfizer Inc. | 3 Months | 3 | EudraCT-2018-003050-24 |
| 2008 | Hypertension | Novartis AG | 4 Monate | 17 | EudraCT- 2006-006068-44 |
| 2019 | Hyperhidrosis | D. August Wolff GmbH & Co. KG | 3 Months | 12 | EudraCT-2017-004534-29 |
| 2008 | Anxiety Disorder (GAD) | Takeda Pharmaceutical Company Ltd. | 2 Monate | 7 | EudraCT-2008-001766-90 |
| 2019 | Herpes Genitalis | Heidelberg ImmunoTherapeutics GmbH | 8 Monate | 108 | EudraCT-2019-000880-26 |
| 2008 | Alzheimer-Disease | IFE Europe GmbH | 1 Monat | 3 | EudraCT-2008-002758-39 |
| 2019 | Psoriasis | Pfizer Inc. | 8 Monate | 5 | EudraCT-2018-003051-38 |
| 2008 | Vaccination | GlaxoSmithKline PLC | 1 Monat | 44 | |
| 2019 | Irritable Bowel Syndrome | SymbioPharm GmbH | 7 Monate | 11 | EudraCT-2018-004626-28 |
| 2008 | Irritable Bowel Syndrome | Menarini Research & Business Service GmbH | 3 months | 24 | |
| 2008 | Overactive Bladder (OAB) | Pfizer Inc. | 4 Monate | 18 | EudraCT-2004-000476-13 |
| 2020 | Vaccination | Vakzine Projekt Management GmbH | 2 months | 156 | EudraCT-2019-002706-46 |
| 2008 | Migraine | Merck Sharp & Dohme GmbH | 3 months | 55 | |
| 2008 | Pain | Lilly Deutschland GmbH | 6 months | 12 | |
| 2003 | Depression | Dr. Willmar Schwabe GmbH & Co. KG | 4 | N.a. | |
| 2008 | Depression | Sanofi-Aventis Deutschland GmbH | 6 Monate | 29 | EudraCT-2004-002328-16 |
| 2020 | Herpes | Heidelberg ImmunoTherapeutics GmbH | 53 | EudraCT--2020-000926-24 | |
| 2008 | Diabetes mellitus | Merck Sharp & Dohme GmbH | 1 month | 4 | |
| 2008 | Depression | H. Lundbeck A/S | 6 Monate | 30 | EudraCT-2008-001580-11 |
| 2008 | Sexual Dysfunction | Bayer AG | 4 Monate | 13 | Eudract-2006-004397-27 |
| 2020 | Vasomotor Symptoms | Sojournix Inc. | 14 | EudraCT-2019-002281-12 | |
| 2008 | Lipometabolic disorder | Merck Sharp & Dohme GmbH | 2 months | 33 | |
| 2008 | Hypertension | Takeda Pharmaceutical Company Ltd. | 2 Monate | 10 | EudraCT-2007-002583-10 |
| 2007 | Sexual Dysfunction | Boehringer Ingelheim International GmbH | 11 Monate | 60 | EudraCT-2007-000032-68 |
| 2020 | Vaccination | Vakzine Projekt Management GmbH | 195 | EudraCT-2020-001675-33 | |
| 2007 | Depression | GlaxoSmithKline PLC | 10 Monate | 36 | EudraCT-2005-003400-11 |
| 2020 | Alopecia Areata | Pfizer Inc. | 4 | EudraCT-2019-001084-71 | |
| 2007 | Depression | Sanofi-Aventis Deutschland GmbH | 10 Monate | 36 | EudraCT-2004-002328-16 |
| 2019 | Prophylaxis (Flu) | Enzymatika AB | 90 | EudraCt- | |
| 2007 | Depression | Servier Forschung und Pharma Entwicklung GmbH | 10 Monate | 16 | EudraCT-2006-004716-48 |
| 2007 | Insomnia | Sanofi-Aventis Deutschland GmbH | 12 Monate | 14 | EudraCT-2006-006677-25 |
| 2019 | Common Cold | Enzymatika AB | 90 | EudraCT- | |
| 2007 | Polyneuropathy, diabetic | Swedish Orphan Biovitrum AB | 2 Monate | 1 | EudraCT- 2006-004007-19 |
| 2018 | Diabetes mellitus | Novo Nordisk A/S | 7 Monate | 4 | EudraCT-2017-003219-20 |
| 2007 | Parkinson Disease | Imerem GmbH | 3 Monate | 1 | |
| 2016 | Fibromyalgia | Daiichi Sankyo Deutschland GmbH | 28 | EudraCT- | |
| 2007 | Polyneuropathy, diabetic | Grünenthal GmbH | 4 Monate | 8 | EudraCT-2006-003132-29 |
| 2016 | Contraception | Mithra Pharmaceuticals | 21 | EudraCT-2015-003150-40 | |
| 2007 | Neuralgia (Zoster) | Grünenthal GmbH | 4 Monate | 8 | |
| 2016 | Atopic Dermatitis | Pfizer Inc. | EudraCT-2015-005513-72 | ||
| 2007 | Hypertension | Daiichi Sankyo Deutschland GmbH | 19 Monate | 19 | EudraCT-2008-008260-28 |
| 2015 | Arthrosis | Pro Bono Bio International Trading Ltd. | 56 | GDCT0269718 | |
| 2007 | Restless Legs Syndrome | Boehringer Ingelheim International GmbH | 4 Monate | 34 | EudraCT-2006-006431-42 |
| 2014 | Obesity | Hanmi Pharm.Co.,Ltd. | 52 | EudraCT-2013-004251-21 | |
| 2007 | Migraine | Merck Sharp & Dohme GmbH | 5 months | 35 | |
| 2014 | Binge Eating Disorder | Shire Pharmaceuticals Group Plc | 1 | EudraCT-2012-003313-34 | |
| 2007 | Anxiety Disorder (GAD) | Sanofi-Aventis Deutschland GmbH | 6 Monate | 16 | EudraCT 2006-002253-71 |
| 2013 | Vaccination, Herpes | GlaxoSmithKline PLC | 11 | EudraCT- 2015-001778-17 | |
| 2007 | Depression | Pierre Fabre S.A | 5 Monate | 11 | EudraCT-2006-002404-34 |
| 2013 | Herpes, Vaccination, Influenza | GlaxoSmithKline PLC | 16 | EudraCT-2013-000372-15 | |
| 2006 | Anxiety Disorder (Phobia) | GlaxoSmithKline PLC | 5 Monate | 16 | EudraCT- 2006-003597-10 |
| 2006 | Hypertension | AstraZeneca PLC | 6 Monate | 50 | EudraCT -2005-005718-19 |
| 2010 | Restless Legs Syndrome | Mundipharma GmbH | 21 | EudraCT-2009-011107-23 |